CORRESP Filing
Caribou Biosciences, Inc.
Date: May 13, 2025 · CIK: 0001619856 · Accession: 0001193125-25-119050
AI Filing Summary & Sentiment
File numbers found in text: 333-287093
Show Raw Text
CORRESP 1 filename1.htm CORRESP CARIBOU BIOSCIENCES, INC. 2929 7th Street Suite 105 Berkeley, California 94710 (510) 982-6030 May 13, 2025 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, D.C. 20549 Attention: Tim Buchmiller Re: Caribou Biosciences, Inc. (the “Registrant”) - Request for Acceleration Registration Statement on Form S-3 File No. 333-287093 Ladies and Gentlemen: Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, the Registrant hereby requests acceleration of the effective date of its Registration Statement on Form S-3 (File No. 333-287093) (the “Registration Statement”), so that it may become effective at 4:00 p.m. Eastern Time on Wednesday, May 14, 2025 , or as soon thereafter as practicable. The Registrant hereby authorizes each of Ashok Mukhey and Danielle Carbone of Reed Smith LLP, attorneys for the Registrant, to orally modify or withdraw this request for acceleration. The Registrant requests that it be notified of such effectiveness by a telephone call to Ashok Mukhey at (310) 734-5291 or, in his absence, Danielle Carbone at (212) 549-0229. CARIBOU BIOSCIENCES, INC. By: /s/ Sriram Ryali Name: Sriram Ryali Title: Chief Financial Officer